New York State Common Retirement Fund Kiniksa Pharmaceuticals, Ltd. Transaction History

New York State Common Retirement Fund

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$17.63 - $21.74 $86,457 - $106,612	4,904 Added 14.06%	39,771 $785,000
Q4 2023 Feb 01, 2024	BUY	$14.37 - $19.07 $299,485 - $397,437	20,841 Added 148.59%	34,867 $612,000
Q3 2023 Nov 07, 2023	BUY	$13.62 - $20.2 $1,334 - $1,979	98 Added 0.7%	14,026 $244,000
Q2 2023 Aug 07, 2023	SELL	$10.44 - $16.48 $480 - $758	-46 Reduced 0.33%	13,928 $196,000
Q1 2023 May 02, 2023	SELL	$10.7 - $15.79 $84,530 - $124,741	-7,900 Reduced 36.12%	13,974 $150,000
Q4 2022 Jan 30, 2023	SELL	$11.42 - $17.05 $114 - $170	-10 Reduced 0.05%	21,874 $328,000
Q3 2022 Nov 08, 2022	BUY	$9.76 - $13.41 $53,543 - $73,567	5,486 Added 33.46%	21,884 $281,000
Q2 2022 Aug 04, 2022	SELL	$7.6 - $11.41 $202,889 - $304,601	-26,696 Reduced 61.95%	16,398 $159,000
Q1 2022 May 05, 2022	BUY	$9.3 - $12.37 $81,998 - $109,066	8,817 Added 25.72%	43,094 $428,000
Q4 2021 Feb 02, 2022	BUY	$10.39 - $15.15 $157,335 - $229,416	15,143 Added 79.14%	34,277 $403,000
Q3 2021 Nov 02, 2021	SELL	$11.39 - $16.23 $61,369 - $87,447	-5,388 Reduced 21.97%	19,134 $218,000
Q2 2021 Aug 02, 2021	BUY	$13.22 - $19.09 $2,934 - $4,237	222 Added 0.91%	24,522 $342,000
Q4 2020 Feb 08, 2021	BUY	$14.8 - $21.15 $99,160 - $141,705	6,700 Added 38.07%	24,300 $429,000
Q2 2020 Aug 07, 2020	BUY	$15.08 - $26.0 $60,320 - $104,000	4,000 Added 29.41%	17,600 $448,000
Q2 2019 Aug 09, 2019	BUY	$13.2 - $20.39 $129,360 - $199,822	9,800 Added 257.89%	13,600 $184,000
Q4 2018 Feb 08, 2019	BUY	$16.25 - $28.09 $61,750 - $106,742	3,800 New	3,800 $107,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.